GSTO1 and neoplasm: RyR1 expression is elevated in chemotherapy-resistant BCSCs, where it promotes calcium release via the glutathione S-transferase omega 1 (GSTO1) pathway; blocking this channel reduces CSC markers like Nanog and tumour volume in mouse models [3].